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During the last four decades we have seen an exponential growth in interventions (both medical and 
invasive) to diagnose and treat adult cardiac disorders. Coronary stents are in their fourth generation and 
the developments in cardiac pacing and electrophysiology has shown the same rapid growth. Large 
numbers of patients at risk who require these treatment modalities have driven these developments 
and the interventions have made a difference to the lives of hundreds of thousands of patients across 
the globe.
Congenital heart disease on the other hand is much rarer and the conditions are often very difficult to 
diagnose correctly. Interventions for congenital heart disease often have to be individualised to a large 
extent due to the fact that patients’ defects tend to be unique. This has lead to a much slower develop-
ment in this field. However, with paediatric cardiologists borrowing ideas from other interventional 
specialities and with the frequent off label use of devices, interventionists in this field have developed a 
unique set of skills not only suited to paediatric interventions but also applicable to adult structural heart 
disease. The emerging role of the structural heart disease interventionist in dealing with a large spectrum 
of cardiac conditions, from infancy to the very elderly, is highlighted in this issue of the SA Heart Journal 
which is dedicated to this topic.
The review of the management of congenital aortic stenosis in the neonate by Mitchell and Brown 
emphasises that treatment in young infants remains a challenging and contentious issue. Some studies 
slightly favour open surgical valvotomy, but on closer inspection a number of these were carried out in 
the early 2000s and some excluded young infants. Technology has changed considerably: newer low 
profile balloons and techniques such as rapid right ventricular pacing has augmented the success of 
balloon valvuloplasty in this age group. It should be realised that both early balloon valvuloplasty as well 
as surgical valvotomy in these infants primarily serve as a bridge towards later surgery. It is also clear that 
other factors such as valve morphology, left ventricular size and function have a significant impact on final 
outcomes.
Gewillig and Brown provide a sobering look at  the management of tetralogy of Fallot and show how 
surgery has proceeded from palliation with poor long term survival to reparative with currently excellent 
long term survival. The article also points out how the emphasis on relief of outflow obstruction led to 
pulmonary regurgitation and right heart dilation which were mostly ignored for decades by physicians 
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until sudden deaths occurred.  He challenges clincians’ concepts of what we consider “normal” and 
proposes a new strategy of earlier intervention using percutaneous valves in children with significant 
pulmonary regurgitation in native outflow tracts. The aim of this strategy would be to prolong life 
expectancy and preserve normal right ventricular function by intervention before irreversible right 
ventricular electro-mechanical dysfunction sets in. However, as the authors point out, the outcome of 
such a strategy will only become evident in 30 - 40 years from now.
Closure of patent foramen ovale after cryptogenic stroke is always controversial as the definition of 
what constitutes a truly cryptogenic stroke is highly variable and many consider PFO as a variant of 
normal, rather than a defect. Andreas Wahl and Bernhard Meier provide a balanced view on the 
management of this condition. The review is written from the perspective of the interventionist 
performing this procedure and whilst acknowledging the lack of evidence for the benefit of closure, they 
argue that although closure cannot be presented as the recommended treatment, it should at least 
be mentioned as an attractive option.
Finally, coming to the older patient in the age spectrum discussed in this issue of the Journal, Mark 
Abelson reviews the data and shares his views on the percutaneous closure of left atrial appendage to 
prevent strokes. This procedure provides a significant risk reduction for patients unable to take anti-
coagulants for chronic AF, but newer data also argues for its use as an alternative to anticoagulants. The 
exact utility in a number of conditions is yet to be determined, but if the safety of the implantation can 
be improved, we will likely see a large expansion of its use in the next few years.
Structural interventions are here to stay and will continue to open up new avenues of treatment. As 
technologies improve more treatment modalities will become available that will benefit all patients, 
from the very young to the very old.
